☆ 4.4 Article

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19

TRIALS (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

Data monitoring committee interim reports: We must get there soon!

David L. DeMets et al.

Summary: Current Data Monitoring Committee Reports lack the necessary information for informed decision-making on risks and benefits; urgent and serious improvements are needed for Data Monitoring Committees to fulfill their ethical, clinical, and scientific responsibilities; all parties involved in the Data Monitoring Committee process should have a better understanding of its structure, function, and needs.

CLINICAL TRIALS (2022)

Add to Collection

News Item Medicine, General & Internal

Nature does things well

[Anonymous]

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

Add to Collection

Article Medicine, General & Internal

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby et al.

Summary: In patients hospitalized with COVID-19, aspirin was not associated with reductions in 28-day mortality or in the risk of progressing to invasive mechanical ventilation or death, but was associated with a small increase in the rate of being discharged alive within 28 days.

LANCET (2022)

Add to Collection

Article Medicine, General & Internal

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani et al.

LANCET (2022)

Add to Collection

Article Medicine, General & Internal

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

P. W. Horby et al.

Summary: Azithromycin has been proposed as a treatment for COVID-19 due to its immunomodulatory actions. However, a study in hospitalized patients with COVID-19 showed that azithromycin did not improve survival or other clinical outcomes. Its use should be restricted to patients with a clear antimicrobial indication.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Peter W. Horby et al.

Summary: Convalescent plasma therapy did not improve survival or other clinical outcomes in hospitalized COVID-19 patients.

LANCET (2021)

Add to Collection

Article Critical Care Medicine

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Group Author Only

Summary: The study aimed to evaluate the efficacy and safety of colchicine in treating COVID-19 patients, but found that it did not reduce 28-day mortality, hospital stay duration, or risk of progressing to invasive mechanical ventilation or death.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

Achieving effective informed oversight by DMCs in COVID clinical trials

David L. DeMets et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)

Add to Collection

Retraction Medicine, General & Internal

撤稿声明: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Retraction of 10.1016/S0140-6736(20)31180-6, 2020)

Mandeep R. Mehra et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

You have to keep your nerve on a DMC. Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study

Claire Snowdon et al.

PLOS ONE (2018)

Add to Collection

Article Medicine, Research & Experimental

Clinician-trialist rounds: 23. When an RCT's Data Center Report drowns vital information in seas of data: Where's Waldo?

Janice Pogue et al.

CLINICAL TRIALS (2014)

Add to Collection

Editorial Material Medicine, General & Internal

More multiarm randomised trials of superiority are needed

Mahesh K. B. Parmar et al.

LANCET (2014)

Add to Collection

Editorial Material Medicine, General & Internal

Data and Safety Monitoring Boards Academic Credit Where Credit Is Due?

Paul W. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.